Author: Xueshu Tao1, Michael S Lee1, Christopher R Donnelly1, Ru-Rong Ji2 3 4
Affiliation: <sup>1</sup> Center for Translational Pain Medicine, Department of Anesthesiology, Duke University Medical Center, Durham, NC, 27710, USA.
<sup>2</sup> Center for Translational Pain Medicine, Department of Anesthesiology, Duke University Medical Center, Durham, NC, 27710, USA. ru-rong.ji@duke.edu.
<sup>3</sup> Department of Neurobiology, Duke University Medical Center, Durham, NC, 27710, USA. ru-rong.ji@duke.edu.
<sup>4</sup> Department of Cell Biology, Duke University Medical Center, Durham, NC, 27710, USA. ru-rong.ji@duke.edu.
Conference/Journal: Neurotherapeutics
Date published: 2020 Jul 21
Other:
Pages: cauthor_id=32696274" ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link" data-ga-label="Xueshu Tao">Xueshu Tao</a><sup class="affiliation-links"><span class="author-sup-separator"> , Special Notes: doi: 10.1007/s13311-020-00892-9. , Word Count: 287
The current crises in opioid abuse and chronic pain call for the development of nonopioid and nonpharmacological therapeutics for pain relief. Neuromodulation-based approaches, such as spinal cord stimulation, dorsal root ganglion simulation, and nerve stimulation including vagus nerve stimulation, have shown efficacy in achieving pain control in preclinical and clinical studies. However, the mechanisms by which neuromodulation alleviates pain are not fully understood. Accumulating evidence suggests that neuromodulation regulates inflammation and neuroinflammation-a localized inflammation in peripheral nerves, dorsal root ganglia/trigeminal ganglia, and spinal cord/brain-through neuro-immune interactions. Specialized proresolving mediators (SPMs) such as resolvins, protectins, maresins, and lipoxins are lipid molecules produced during the resolution phase of inflammation and exhibit multiple beneficial effects in resolving inflammation in various animal models. Recent studies suggest that SPMs inhibit inflammatory pain, postoperative pain, neuropathic pain, and cancer pain in rodent models via immune, glial, and neuronal modulations. It is noteworthy that sham surgery is sufficient to elevate resolvin levels and may serve as a model of resolution. Interestingly, it has been shown that the vagus nerve produces SPMs and vagus nerve stimulation (VNS) induces SPM production in vitro. In this review, we discuss how neuromodulation such as VNS controls pain via immunomodulation and neuro-immune interactions and highlight possible involvement of SPMs. In particular, we demonstrate that VNS via auricular electroacupuncture effectively attenuates chemotherapy-induced neuropathic pain. Furthermore, auricular stimulation is able to increase resolvin levels in mice. Thus, we propose that neuromodulation may control pain and inflammation/neuroinflammatioin via SPMs. Finally, we discuss key questions that remain unanswered in our understanding of how neuromodulation-based therapies provide short-term and long-term pain relief.
KEYWORDS: Auricular stimulation; chemotherapy; dorsal root ganglion; fish oil; resolvin; vagus nerve stimulation.
PMID: 32696274 DOI: 10.1007/s13311-020-00892-9